Friday November 18, 2016 |
08:00 | Registration |
|
08:50 | Opening |
Dr Laurent PROVINS (UCB, Braine-l'Alleud, Belgium) |
09:00 | PL01 - PET Tracer Development and Translation to the Clinic |
Prof Guy BORMANS (KULEUVEN, Leuven, Belgium) |
09:50 | PL02 - PET Chemistry: Routine Application, Recent Advances and Ongoing Challenges |
Dr Jan PASSCHIER (IMANOVA, London, United Kingdom) |
10:40 | Coffee Break & Exhibition |
|
11:15 | OC01 - Late-Stage Fluorination for PET Imaging |
Prof. Tobias RITTER (MAX-PLANCK-INSTITUT FÜR KOHLENFORSCHUNG, Mulheim, Germany) |
11:45 | PL03 - Clinical Imaging Agents, and the Art of Medicinal Chemistry |
Dr Yves P. AUBERSON (NOVARTIS INSTITUTES FOR BIOMEDICAL RESEARCH, Basel, Switzerland) |
12:35 | Lunch, Exhibition & Poster Session I |
|
14:00 | PL04 - SV2A Imaging and the Potential Applications in Neurodegenerative Disorders |
Prof. Eric SALMON (ULG, Belgium) |
14:50 | OC02 - Synthesis and in vivo PET Evaluation of a 18F Bile Acid to Assess Drug-Induced Liver Injury in Mice |
Mr Stef DE LOMBAERDE (GHENT UNIVERSITY, Gent, Belgium) |
15:10 | OC03 - in vivo Evaluation of Novel 18F-Labeled TCO Analogues for Pretargeted Immuno-PET Imaging in a HER2 Positive Cancer Model |
Mr Jens FISSERS (UNIVERSITY OF ANTWERP, Antwerpen, Belgium) |
15:30 | Coffee Break, Exhibition & Poster Session II |
|
16:05 | PL05 - Antibody Imaging and Therapy Using in Vivo Click and Click-to-Release Strategies |
Dr Marc ROBILLARD (TAGWORKS PHARMACEUTICALS, Eindhoven, The Netherlands) |
16:55 | PL06 - The Value of PET Ligand Discovery to CNS Drug Development |
Dr Mark SCHMIDT (JANSSEN PHARMACEUTICA, Beerse, Belgium) |
17:45 | Closing Remarks |
Prof. Koen AUGUSTYNS (UNIVERSITY OF ANTWERP, Antwerp, Belgium) |